Skip to main content
Top
Published in: Endocrine 3/2007

01-06-2007 | Original Paper

Depletion of the catalytic subunit of protein phosphatase-2A (PP2Ac) markedly attenuates glucose-stimulated insulin secretion in pancreatic β-cells

Authors: Giridhar R. Jangati, Rajakrishnan Veluthakal, Laura Susick, Scott A. Gruber, Anjaneyulu Kowluru

Published in: Endocrine | Issue 3/2007

Login to get access

Abstract

Among various phosphatases, the protein phosphatase 2A (PP2A) is relatively well studied in the islet. Previously, we have demonstrated that the catalytic subunit of PP2A (PP2Ac) undergoes okadaic acid (OKA)-sensitive, reversible carboxylmethylation (CML), which appears to be requisite for glucose-stimulated insulin secretion (GSIS). Using the siRNA approach, we examined, herein, the contributory roles of PP2Ac in GSIS from insulin-secreting pancreatic β-(INS-1 832/13) cells. Immunologically, PP2Ac was detectable in all the subcellular fractions studied in rank order of: cytosol > microsomes > secretory granules = nucleus > mitochondria. Transfection of PP2Ac-specific, but not scrambled-siRNA, markedly attenuated PP2A activity and GSIS in these cells. Together, our findings provide a direct evidence for a positive modulatory role for PP2Ac in signaling steps leading to GSIS.
Literature
1.
5.
go back to reference A. Kowluru, S.E. Seavey, M.E. Rabaglia, R. Nesher, S.A. Metz, Endocrinology 137, 2315–2323 (1996)PubMedCrossRef A. Kowluru, S.E. Seavey, M.E. Rabaglia, R. Nesher, S.A. Metz, Endocrinology 137, 2315–2323 (1996)PubMedCrossRef
6.
go back to reference A. Kowluru, S.A. Metz, Biosci. Rep. 18, 171–186 (1998) A. Kowluru, S.A. Metz, Biosci. Rep. 18, 171–186 (1998)
7.
go back to reference A. Sjoholm, M. Lehtihet, A.M. Efanov, S.V. Zaitsev, P.O. Berggren, Endocrinology 143, 4592–4598 (2002)PubMedCrossRef A. Sjoholm, M. Lehtihet, A.M. Efanov, S.V. Zaitsev, P.O. Berggren, Endocrinology 143, 4592–4598 (2002)PubMedCrossRef
8.
go back to reference R. Palanivel, R. Veluthakal, A. Kowluru, Am. J. Physiol. Endocrinol. Metab. 286, 1032–1041 (2004)CrossRef R. Palanivel, R. Veluthakal, A. Kowluru, Am. J. Physiol. Endocrinol. Metab. 286, 1032–1041 (2004)CrossRef
10.
go back to reference S. Strack, J.A. Zaucha, F.F. Ebner, R.J. Colbran, B.E. Wadzinski, J. Comp. Neurol. 392, 515–527 (1998)PubMedCrossRef S. Strack, J.A. Zaucha, F.F. Ebner, R.J. Colbran, B.E. Wadzinski, J. Comp. Neurol. 392, 515–527 (1998)PubMedCrossRef
11.
go back to reference N. Leulliot, S. Quevillon-Cheruel, I. Sorel, I.L. de La Sierra-Gallay, B. Collinet, M. Graille, K. Blondeau, N. Bettache, A. Poupon, J. Janin, H. van Tilbeurgh, J. Biol. Chem. 279, 8351–8358 (2004)PubMedCrossRef N. Leulliot, S. Quevillon-Cheruel, I. Sorel, I.L. de La Sierra-Gallay, B. Collinet, M. Graille, K. Blondeau, N. Bettache, A. Poupon, J. Janin, H. van Tilbeurgh, J. Biol. Chem. 279, 8351–8358 (2004)PubMedCrossRef
13.
14.
15.
go back to reference B. Favre, S. Zolnierowicz, P. Turowski, B.A. Hemmings, J. Biol. Chem. 269, 16311–16317 (1994)PubMed B. Favre, S. Zolnierowicz, P. Turowski, B.A. Hemmings, J. Biol. Chem. 269, 16311–16317 (1994)PubMed
16.
go back to reference P. Turowski, A. Fernandez, B. Favre, N.J.C. Lamb, B.A. Hemmings, J. Cell. Biol. 129, 397–410 (1995)PubMedCrossRef P. Turowski, A. Fernandez, B. Favre, N.J.C. Lamb, B.A. Hemmings, J. Cell. Biol. 129, 397–410 (1995)PubMedCrossRef
20.
21.
23.
go back to reference J. Li, R. Luo, A. Kowluru, G. Li, Amer. J. Physiol. Endocrinol. Metab. 286, E818–E827 (2004)CrossRef J. Li, R. Luo, A. Kowluru, G. Li, Amer. J. Physiol. Endocrinol. Metab. 286, E818–E827 (2004)CrossRef
24.
go back to reference A. Krautheim, I. Rustenbeck, H.J. Steinfelder, Exp. Clin. Endocrinol. Diabetes. 107, 29–34 (1999)PubMedCrossRef A. Krautheim, I. Rustenbeck, H.J. Steinfelder, Exp. Clin. Endocrinol. Diabetes. 107, 29–34 (1999)PubMedCrossRef
25.
26.
go back to reference H.P. Ammon, R.O. Heurich, H.A. Kolb, F. Lang, R. Schaich, G. Drews, T. Leiers, Naunyn. Schmiedebergs. Arch. Pharmacol. 354, 95–101 (1996)PubMedCrossRef H.P. Ammon, R.O. Heurich, H.A. Kolb, F. Lang, R. Schaich, G. Drews, T. Leiers, Naunyn. Schmiedebergs. Arch. Pharmacol. 354, 95–101 (1996)PubMedCrossRef
28.
go back to reference T. Tamagawa, A. Iguchi, K. Uemura, H. Miura, K. Nonogaki, T. Ishiguro, Endocrinol. Jpn. 39, 325–329 (1992)PubMed T. Tamagawa, A. Iguchi, K. Uemura, H. Miura, K. Nonogaki, T. Ishiguro, Endocrinol. Jpn. 39, 325–329 (1992)PubMed
30.
31.
go back to reference J. Arino, C.W. Woon, T.B. Brantigan, T.B. Miller, G.L. Johnson, Proc. Natl. Acad. Sci. USA 85, 4252–4256 (1988)PubMedCrossRef J. Arino, C.W. Woon, T.B. Brantigan, T.B. Miller, G.L. Johnson, Proc. Natl. Acad. Sci. USA 85, 4252–4256 (1988)PubMedCrossRef
32.
go back to reference Y. Khew-Goddall, R.E. Mayer, F. Maurer, S.R. Stone, B.A. Hemmings, Biochemistry 30, 89–97 (1991)CrossRef Y. Khew-Goddall, R.E. Mayer, F. Maurer, S.R. Stone, B.A. Hemmings, Biochemistry 30, 89–97 (1991)CrossRef
33.
go back to reference T. Ikehara, F. Shinjo, S. Ikehara, S. Imamura, T. Yasumoto, Protein Expr. Purif. 45, 150–156 (2006)PubMedCrossRef T. Ikehara, F. Shinjo, S. Ikehara, S. Imamura, T. Yasumoto, Protein Expr. Purif. 45, 150–156 (2006)PubMedCrossRef
Metadata
Title
Depletion of the catalytic subunit of protein phosphatase-2A (PP2Ac) markedly attenuates glucose-stimulated insulin secretion in pancreatic β-cells
Authors
Giridhar R. Jangati
Rajakrishnan Veluthakal
Laura Susick
Scott A. Gruber
Anjaneyulu Kowluru
Publication date
01-06-2007
Publisher
Humana Press Inc
Published in
Endocrine / Issue 3/2007
Print ISSN: 1355-008X
Electronic ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-007-0046-3

Other articles of this Issue 3/2007

Endocrine 3/2007 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.